These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1707106)

  • 21. Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension.
    Korner PI; Jennings GL; Esler MD
    J Clin Hypertens; 1987 Sep; 3(3):341-8. PubMed ID: 2959758
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 23. [Introducing mibefradil--a new T-calcium channel blocker].
    Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
    [No Abstract]   [Full Text] [Related]  

  • 24. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Materson BJ; Reda DJ; Preston RA; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R
    Arch Intern Med; 1995 Sep; 155(16):1757-62. PubMed ID: 7654109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension.
    Bond G; Dal Palú C; Hansson L; Magnani B; Mancia G; Neiss A; Rahn KH; Reid JL; Rodicio JL; Safar M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S85-7. PubMed ID: 7609514
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ambulatory therapy of hypertension with briserin mite].
    Schütz E
    Med Welt; 1970 May; 22():1040-3. PubMed ID: 5509755
    [No Abstract]   [Full Text] [Related]  

  • 29. What is apoptosis and what is its relevance to vascular biology?
    Hamet P
    Can J Cardiol; 1999 Apr; 15 Suppl B():5B-7B. PubMed ID: 10350674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of arteriosclerosis with reference to the so-called "risk factors"].
    Emmrich R
    Munch Med Wochenschr; 1968 Aug; 110(35):1918-23. PubMed ID: 5695702
    [No Abstract]   [Full Text] [Related]  

  • 32. [Also for problem cases; successful first line therapy].
    MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
    [No Abstract]   [Full Text] [Related]  

  • 33. Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis.
    Giannattasio C; Boutouyrie P; Glen S; Mallion J; Reid J; Laurent S; Mancia G
    Blood Press Suppl; 1996; 4():39-43. PubMed ID: 8973782
    [No Abstract]   [Full Text] [Related]  

  • 34. [New approaches in choosing the therapy of patients with hypertension].
    Ol'binskaia LI; Stiazhkin VIu; Iamshchikov SN
    Ter Arkh; 1989; 61(9):24-9. PubMed ID: 2531936
    [No Abstract]   [Full Text] [Related]  

  • 35. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An evaluation of the therapeutic trials aimed at regression of ventricular hypertrophy in arterial hypertension].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):503-8. PubMed ID: 1836942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different antihypertensive drug classes on survival in animal models.
    Knorr A; Garthoff B; Kazda S; Stasch JP
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S94-100. PubMed ID: 1715494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Left axis deviation and left anterior hemiblock in patients with essential hypertension during antihypertensive treatment (author's transl)].
    Patzschke U; Manegold C
    Herz; 1980 Aug; 5(4):246-50. PubMed ID: 6456213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Omboni S; Ravogli A; Villani A; Santucciu C; Ulian L
    Blood Press Suppl; 1996; 4():36-8. PubMed ID: 8973781
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective Ang II (AT1) receptor blockade: a rational approach to end-organ protection in hypertension.
    Burnier M
    Int J Clin Pract Suppl; 2000 Aug; (111):9-13. PubMed ID: 15977401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.